Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 315,269 | 264,714 | 240,760 | 216,310 | 175,712 |
| Operating Income | -315,269 | -264,714 | -240,760 | -216,310 | -175,712 |
| Interest Expense | 11,428 | 0 | 0 | 0 | 0 |
| Other Income | 21,491 | 16,927 | 27,344 | 20,988 | 19,424 |
| Pre-tax Income | -305,206 | -247,787 | -213,416 | -195,322 | -156,288 |
| Net Income Continuous | -305,206 | -247,787 | -213,416 | -194,569 | -156,288 |
| Net Income | $-305,206 | $-247,787 | $-213,416 | $-194,569 | $-156,288 |
| EPS Basic Total Ops | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 |
| EPS Basic Continuous Ops | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 |
| EPS Diluted Total Ops | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 |
| EPS Diluted Continuous Ops | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -1.61 | -1.31 | -1.13 | -1.12 | -0.94 |
| EBITDA(a) | $-316,648 | $-268,655 | $-246,861 | $-221,749 | $-182,428 |